Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DoBo: Doxycycline + Hydroxychloroquine in Lyme Borreliosis
NCT07230028Phase 4Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2027
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of hydroxychloroquine in Lyme borreliosis, sponsored by Radboud University Medical Center. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
Lyme borreliosis
Beyond the preview
Go deeper on NCT07230028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230028.